1

Retasturtide: A Novel GLP-1 Receptor Agonist for Type 2 Diabetes

News Discuss 
Retasturtide is a recently developed novel drug demonstrating encouraging results in the treatment of type 2 diabetes. This synthetic peptide duplicates the actions of naturally present GLP-1, a hormone that plays a https://getidealist.com/story22693873/retasturtide-a-novel-glp-1-receptor-agonist-for-type-2-diabetes

Comments

    No HTML

    HTML is disabled


Who Upvoted this Story